Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial (vol 36, pg 2508, 2013)

被引：0
作者：
Tomita, K.
机构：
来源：
DIABETES CARE | 2013年 / 36卷 / 12期
关键词：
D O I：
10.2337/dc13-er12b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4172 / 4172
页数：1
相关论文
共 50 条
[31]   Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial (vol 11, pg 193, 2013) [J].
Bailey, Clifford J. ;
Gross, Jorge L. ;
Hennicken, Delphine ;
Iqbal, Nayyar ;
Mansfield, Traci A. ;
List, James F. .
BMC MEDICINE, 2013, 11
[32]   Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial [J].
Buse, John B. ;
Bode, Bruce W. ;
Mertens, Ann ;
Cho, Young Min ;
Christiansen, Erik ;
Hertz, Christin L. ;
Nielsen, Morten A. ;
Pieber, Thomas R. .
BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (02)
[33]   Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial [J].
Jabbour, Serge A. ;
Frias, Juan P. ;
Hardy, Elise ;
Ahmed, Azazuddin ;
Wang, Hui ;
Ohman, Peter ;
Guja, Cristian .
DIABETES CARE, 2018, 41 (10) :2136-2146
[34]   Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial [J].
Peng, Xuejun V. ;
Marcinak, John F. ;
Raanan, Marsha G. ;
Cao, Charlie .
DIABETES OBESITY & METABOLISM, 2017, 19 (08) :1127-1134
[35]   Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial [J].
Nauck, M. A. ;
Meininger, G. ;
Sheng, D. ;
Terranella, L. ;
Stein, P. P. .
DIABETES OBESITY & METABOLISM, 2007, 9 (02) :194-205
[36]   Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy [J].
Frias, Juan P. ;
Maaske, Jill ;
Suchower, Lisa ;
Johansson, Lars ;
Hockings, Paul D. ;
Iqbal, Nayyar ;
Wilding, John P. H. .
DIABETES OBESITY & METABOLISM, 2022, 24 (01) :61-71
[37]   Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial (vol 11, pg 611, 2009) [J].
Jadzinsky, M. ;
Pfuetzner, A. ;
Paz-Pacheco, F. ;
Xu, Z. ;
Allen, F. ;
Chen, R. .
DIABETES OBESITY & METABOLISM, 2010, 12 (05) :462-462
[38]   Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallel-group trial (vol 7, pg 76, 2016) [J].
Kaku, K. ;
Kiyosue, A. ;
Ono, Y. ;
Shiraiwa, T. ;
Kaneko, S. ;
Nishijima, K. ;
Bosch-Traberg, H. ;
Seino, Y. .
JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (02) :279-279
[39]   Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial [J].
Wang, Weiqing ;
Nevarez, Luis ;
Filippova, Ekaterina ;
Song, Ki Ho ;
Tao, Bei ;
Gu, Liqun ;
Wang, Feng ;
Li, Pengfei ;
Yang, Jun .
DIABETES OBESITY & METABOLISM, 2019, 21 (02) :234-243
[40]   Long-Term Glycemic Control in Patients Treated with Exenatide Twice Daily and Reduced Body Weight with 10 μg Exenatide: A 52-Week, Randomized, Phase 3 Study in Japanese Patients with Type 2 Diabetes Mellitus [J].
Ueki, Kohjiro ;
Inagaki, Nobuya ;
Yamamura, Ayuko ;
Saito, Hitoshi ;
Imaoka, Takeshi .
DIABETES, 2011, 60 :A614-A614
12345